Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial

M. K. Han, G. J. Criner, M. T. Dransfield, D. M. G. Halpin, C. E. Jones, S. Kilbride, P. Lange, D. A. Lipson, D. A. Lomas, F. J. Martinez, I. Naya, S. J. Pascoe, R. A. Wise, D. Singh

Original languageEnglish
Article numberA102
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume199
Issue numberA2438
ISSN1073-449X
DOIs
Publication statusPublished - 2019

Cite this